Literature DB >> 24611952

Letter to the authors concerning the accepted manuscript: exploring the link between pholcodine and neuromuscular anaphylaxis by Brush et al.

Astrid Uyttebroek1, Julie Leysen, Chris Bridts, Didier Ebo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24611952      PMCID： PMC4239986          DOI： 10.1111/bcp.12374

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

Review 1.  On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective.

Authors:  B A Baldo; M M Fisher; N H Pham
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

2.  Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively.

Authors:  E Florvaag; S G O Johansson; H Oman; L Venemalm; F Degerbeck; T Dybendal; M Lundberg
Journal:  Acta Anaesthesiol Scand       Date:  2005-04       Impact factor: 2.105

3.  Allergy to rocuronium: from clinical suspicion to correct diagnosis.

Authors:  J Leysen; C H Bridts; L S De Clerck; M Vercauteren; J Lambert; J J Weyler; W J Stevens; D G Ebo
Journal:  Allergy       Date:  2011-03-06       Impact factor: 13.146

Review 4.  Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis.

Authors:  Anna M Brusch; Russell C Clarke; Peter R Platt; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

5.  Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice.

Authors:  P M Mertes; J M Malinovsky; L Jouffroy; W Aberer; I Terreehorst; K Brockow; P Demoly
Journal:  J Investig Allergol Clin Immunol       Date:  2011       Impact factor: 4.333

6.  Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide.

Authors:  D G Ebo; C H Bridts; M M Hagendorens; C H Mertens; L S De Clerck; W J Stevens
Journal:  Allergy       Date:  2006-08       Impact factor: 13.146

7.  Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011.

Authors:  P H M Sadleir; R C Clarke; D L Bunning; P R Platt
Journal:  Br J Anaesth       Date:  2013-01-18       Impact factor: 9.166

8.  IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry.

Authors:  J Leysen; L De Witte; V Sabato; M Faber; M Hagendorens; C Bridts; L De Clerck; D Ebo
Journal:  Cytometry B Clin Cytom       Date:  2013-01-25       Impact factor: 3.058
  8 in total
  2 in total

1.  Response to letter regarding article 'Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis'.

Authors:  Anna M Brusch; Russell C Clarke; Peter R Platt; Elizabeth Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

Review 2.  The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 Response.

Authors:  Rob C Aalberse; Thomas A Platts-Mills; Theo Rispens
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.